GlassScriptPhysician profile
Alan J Conrad
NPI 1447258116
$1,387.35
in general payments reported to CMS, 2019-2025
21 companies · $15.33 in 2025
The $15.33 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $73.36 · 2021: $146 · 2022: $132 · 2023: $393 · 2024: $166 · 2025: $15.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $266.92 | 2021-2025 | Ubrelvy, Qulipta |
| Novo Nordisk INC | $242.48 | 2019-2024 | Wegovy, Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $160.59 | 2019-2023 | Arexvy, Nucala |
| Pfizer INC. | $124.23 | 2019 | |
| Sunovion Pharmaceuticals INC. | $74.49 | 2019 | |
| Medtronic, INC. | $65.51 | 2021-2023 | Closurefast |
| Dexcom, INC. | $57.18 | 2023 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $48.59 | 2019-2021 | |
| Amgen INC. | $46.96 | 2023-2024 | Otezla, Repatha |
| Jazz Pharmaceuticals INC. | $46.08 | 2024 | |
| Inspire Medical Systems, INC. | $45.07 | 2023 | Inspire |
| Nestle Healthcare Nutrition INC. | $44.52 | 2023 | |
| Allergan, INC. | $27.19 | 2019-2020 | |
| Aimmune Therapeutics, INC. | $27.07 | 2024 | |
| Janssen Pharmaceuticals, INC | $24.54 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $18.33 | 2019 | |
| Horizon Therapeutics Plc | $16.44 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.93 | 2021 | |
| Merck Sharp & Dohme LLC | $12.64 | 2019 | |
| Ironshore Pharmaceuticals INC. | $11.42 | 2019 | |
| Astellas Pharma US INC | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Conrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.